If continuing GLP-1 therapy, you should have a stable dosing regimen and understand the implications for surgery
That means we know a lot, but we do not know everything yet
This loss of GLP-1 secretion is part of the pathophysiological explanation for a lost incretin effect [13, 14], a phenomenon typically observed in patients with type 2 diabetes
Lay out two large pieces of aluminum foil: place salmon fillets and asparagus on each
Energy metabolism in ischemic heart disease Ischemic heart disease, caused by reduced coronary blood flow, profoundly affects cardiac energy metabolism (Fig
Gasoyan added that, in this large observational study of patients who discontinued semaglutide or tirzepatide, reinitiation of the original medication or receipt of alternative obesity treatment was common, which may explain why they regained less weight than patients in randomized trials. Additionally, previous research suggests that GLP-1 drug discontinuation often occurs for practical reasons rather than lack of effectiveness